期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
氯氮平在美国的应用现状(英文) 被引量:1
1
作者 Deanna L.KELLY Heidi J.WEHRING gopal vyas 《上海精神医学》 2012年第2期110-113,共4页
Clozapine is the only antipsychotic in the United States that has been approved by the Food and Drug Administration (FDA) for treatment-resistant schizophrenia. It provides effective treatment even when patients do no... Clozapine is the only antipsychotic in the United States that has been approved by the Food and Drug Administration (FDA) for treatment-resistant schizophrenia. It provides effective treatment even when patients do not respond to other second- generation antipsychotics.[1] It also remains the most effective antipsychotic available. No existing first or second-generation antipsychotic has been 展开更多
关键词 氯氮平 美国 精神分裂症 精神病 药物 FDA 管理局 第二代
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部